Wolverine Trading’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,700
Closed -$10.3K 5502
2024
Q4
$10.3K Sell
12,700
-9,300
-42% -$8.52K ﹤0.01% 5154
2024
Q3
$22.4K Buy
+22,000
New +$30.2K ﹤0.01% 4626
2024
Q2
Sell
-42,500
Closed -$69.7K 5013
2024
Q1
$69.7K Buy
+42,500
New +$35.6K ﹤0.01% 4141
2023
Q1
Sell
-42,500
Closed -$55K 4732
2022
Q4
$55K Buy
+42,500
New +$66.2K ﹤0.01% 3560
2022
Q2
Sell
-109,400
Closed -$369K 5354
2022
Q1
$369K Buy
+109,400
New +$384K ﹤0.01% 3643
2021
Q4
Sell
-229,200
Closed -$1.56M 6543
2021
Q3
$1.56M Sell
229,200
-89,400
-28% -$656K ﹤0.01% 2443
2021
Q2
$2.69M Buy
+318,600
New +$2.69M ﹤0.01% 1686

Other funds holding OCGN

Wolverine Trading's OCGN Position: Q2 2024 in Review

Wolverine Trading sold out of Ocugen (OCGN) in Q2 2024, closing a stake of 23,528 shares — an estimated $38.6K sold.

Wolverine Trading first reported a position in OCGN in Q2 2021 and held it in 4 quarters. The position peaked at $223K in Q3 2021. 101 funds tracked by Wall St. Rank hold OCGN as of Q2 2024.

  • Wolverine Trading reported no remaining Ocugen position as of Q2 2024 after selling out during the quarter.
  • Wolverine Trading sold 23,528 Ocugen shares in Q2 2024, an estimated $38.6K.
  • Wolverine Trading first reported a position in Ocugen in Q2 2021 and held it in 4 quarters.
  • Wolverine Trading's Ocugen position peaked at $223K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Ocugen as of Q2 2024.

Based on Wolverine Trading's 13F filing for Q2 2024, filed 14 Aug 2024.